Optimization of culture conditions and scale-up to pilot and plant scales for vancomycin production by Amycolatopsis orientalis

Applied Microbiology and Biotechnology

Volumn 77, Issue 4, 2007, Pages 789-795

  Jung, Hyung Moo ^a   Kim, Sang Yong ^a   Moon, Hee Jung ^b   Oh, Deok Kun ^b   Lee, Jung Kul ^b  

^a BioNgene Co Ltd   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

Amycolatopsis orientalis; DOT; Impeller tip velocity; Optimization of culture conditions; Scale up; Vancomycin

Indexed keywords

CELL CULTURE; CELLS; DISSOLVED OXYGEN; OPTIMIZATION; PH EFFECTS; PLANTS (BOTANY);

AMYCOLATOPSIS ORIENTALIS; CULTURE CONDITIONS; IMPELLER TIP VELOCITY; VANCOMYCIN;

ANTIBIOTICS;

DISSOLVED OXYGEN; VANCOMYCIN;

ANTIBIOTICS; BACTERIUM; DISSOLVED OXYGEN; OPTIMIZATION; PH;

ACTINOMYCETACEAE; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BIOREACTOR; CULTURE OPTIMIZATION; LABORATORY TEST; NOCARDIA; NOCARDIA ORIENTALIS; NONHUMAN; PH MEASUREMENT; SCALE UP; VELOCITY; WEIGHT;

ACTINOMYCETALES; CULTURE MEDIA; FERMENTATION; HYDROGEN-ION CONCENTRATION; INDUSTRIAL MICROBIOLOGY; PILOT PROJECTS; VANCOMYCIN;

AMYCOLATOPSIS ORIENTALIS;

EID: 36348931017     PISSN: 01757598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00253-007-1221-4     Document Type: Article

References (25)

1. Barna JCJ, Williams DH (1984) The structure and mode of action of glycopeptide antibiotics of the vancomycin group. Annu Rev Microbiol 38:339-357
2. Beam TR (1981) Vancomycin therapy of experimental pneumococcal meningitis caused by penicillin-sensitive and resistant strains. J Antimicrob Chemother 7:89-99
3. Brunker P, Minas W, Kallio PT, Bailey JE (1998) Genetic engineering of an industrial strain of Saccharopolyspora erythraea for stable expression of the Vitreoscilla haemoglobin gene. (vhb). Microbiology 144:2441-2448
4. Clark GJ, Langley D, Bushell ME (1995) Oxygen limitation can induce microbial secondary metabolite formation: investigations with miniature electrodes in shaker and bioreactor culture. Microbiology 141:663-669
5. Cook FV, Farrar WE (1978) Vancomycin revisited. Ann Intern Med 88:813-818
6. Cunha BA, Quintiliani R, Deglin JM, Izard MW, Nightingale CH (1981) Pharmacokinetics of vancomycin in Anuria. Rev Infect Dis 3:S269-S272
7. DeModena JA, Gutierrez S, Velasco J et al (1993) The production of Cephalosporin C by Acremonium chrysogenum is improved by the intracellular expression of a bacterial hemoglobin. Bio/Technology 11:926-929
8. Dunstan GH, Avignone-Rossa C, Langley D, Bushell ME (2000) The vancomycin biosynthesis pathway is induced in oxygen-limited Amycolatopsis orientalis (ATCC 19795) cultures that do not produce antibiotic. Enz Microbial Technol 27:502-510
9. Farber BF, Moellering RC, Bodey GP Sr (1981) Comparison of vancomycin disposition in rats with normal and abnormal renal functions. Antimicrob Agents Chemother 20:138-141
10. Hyun HH, Jung HM, Kim SY, Lee JK, Yoo SR (2001) Amycolatopsis orientalis mutant starin producing vancomycin and fermentation method of vancomycin using the same. Korean Patent no. 0421712
11. Inman EL (1987) Determination of vancomycin related substances by gradient high-performance liquid chromatography. J Chromatogr 410:363-372
12. Ishizaki A, Tanasaki S, Furuta Y (1993) Cell recycle fermentation of glutamate using a novel cross-flow filtration system with a constant air supply. J Ferment Bioeng 76:316-320
13. 2+ supplementation augments vancomycin production by Amycolatopsis orientalis. Biotechnol Lett 24:293-296
14. Kwak JK, Koo JG, Park SW, Cho MG, Kang BC, Buchholz R, Goetz P (2005) Optimal criterion for the scale-up production of schizophyllan in the stirred tank reactor. J Microbiol Biotechnol 15:1-6
15. Kim HJ, Kim JH, Oh JH, Shin CS (2002) Morphology control of Monascus cells and scale-up of pigment fermentation. Process Biochem 38:649-655
16. Lee JW, Jung YT, Seo JW, Lee KS (2006) Process of purifying vancomycin hydrochloride. US Patent no. 7,018,814
17. Mcintyre JJ, Bunch AW, Bull AT (1999) Vancomycin production is enhanced in chemostat culture with biomass-recycle. Biotechnol Bioeng 62:576-582
18. McCormick MH, Stark WM, Pittenger GE, Pittenger RC, McGuire JM (1956) Vancomycin, a new antibiotic. I. Chemical and biological properties. Antibiot Annu 1955-1956:601-611
19. Mertz FP, Doolin LE (1973) The effect of inorganic phosphate on the biosynthesis of vancomycin. Can J Microbiol 19:263-270
20. Minas W, Brunker P, Kallio PT, Bailey JE (1998) Improved erythromycin production in a genetically engineered industrial strain of Saccharopolyspora erythraea. Biotechnol Progr 14:561-566
21. Nagarajan R (1991) Antibacterial activities and modes of action of vancomycin and related glycopeptides. Antimicrob Agents Chemother 35:605-609
22. Nagy M, Jarai M, Financsek I, Varga I, Kocsis G, Muri V, Andras A, Kegl L, Zlatos G, Kollar E, Udvardy A, Garamvolgyi M (1993) Process for the preparation of vancomycin. US Patent no. 5,223,413
23. Norden CW, Shaffer M (1983) Treatment of experimental chronic osteomyelitis due to Staphylococcus aureus with vancomycin and rifampicin. J Infect Dis 147:352-357
24. Tanaka H, Takahashi J, Ueda K (1975) A standard for the intensity of agitation shock on mycelia on agitation of mycelial suspensions. J Ferment Technol 53:18-26
25. Wang DIC, Cooney CL (1997) Translation of laboratory, pilot, and plant scale data. In: Wang DIC et al (ed) Fermentation and enzyme technology. Wiley, New York, p 194-211